

Product: Tofacitinib
Description: CAS: 540737-29-9; tofacitinib manufacturer; tofacitinib vitiligo; alopecia tofacitinib
Category: Rhematoid Arthritis
In-stock: In Stock
Payment Method: T/T, L/C
Shipping Method: AIR, Express
Product Information
CAS No. |
540737-29-9
|
End Use |
Tofacitinib
|
M.F. |
C22H28N6O8
|
M.W. | 504.50 |
Assay | 98% |
Shelf Life | 2 Years |
Package | 25kg/drum |
Highlight | Tofacitinib Citrate 540737-29-9 Tofacitinib vitiligo CAS: 540737-29-9 CAS: 540737-29-9 alopecia tofacitinib |
Related Products
Additional Information
Application
- Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients.
-
- Melting Point: 201 °C (decomp)
Solubility: Soluble in DMSO (100 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), DMF (~5 mg/ml)
Appearance: Powder
Color: White to beige
Storage Condition: Room temp
MDL: MFCD11616529
Use: A selective JAK3 inhibitor